Aliases & Classifications for Cerebral Hemorrhage

MalaCards integrated aliases for Cerebral Hemorrhage:

Name: Cerebral Hemorrhage 38 29

Summaries for Cerebral Hemorrhage

MalaCards based summary : Cerebral Hemorrhage is related to cerebral amyloid angiopathy, app-related and cerebral amyloid angiopathy, cst3-related, and has symptoms including seizures, tremor and angina pectoris. An important gene associated with Cerebral Hemorrhage is CST3 (Cystatin C), and among its related pathways/superpathways are Neuroscience and MSP-RON Signaling. The drugs Cilostazol and Probucol have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and bone, and related phenotypes are cardiovascular system and muscle

Related Diseases for Cerebral Hemorrhage

Diseases related to Cerebral Hemorrhage via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 194)
# Related Disease Score Top Affiliating Genes
1 cerebral amyloid angiopathy, app-related 33.6 APP CST3
2 cerebral amyloid angiopathy, cst3-related 33.5 APP CST3
3 hemorrhage, intracerebral 32.3 APP CST3
4 alzheimer disease 29.8 APP CST3 GFAP IL1B
5 hereditary cerebral amyloid angiopathy 29.8 APP CST3
6 encephalitis 29.8 GFAP IL1B
7 brain edema 29.8 GFAP IL1B
8 arteries, anomalies of 29.2 APOB IL1B
9 heart disease 29.1 APOB CST3 IL1B
10 myocardial infarction 29.0 APOB CST3 IL1B
11 eclampsia 11.3
12 cerebral cavernous malformation, familial 11.1
13 cerebral cavernous malformations 11.0
14 thrombocytopenia 1 11.0
15 amyloidosis 10.5
16 thrombosis 10.1
17 binswanger's disease 10.1 APP GFAP
18 endocarditis 10.1
19 scrapie 10.1 APP GFAP
20 vascular dementia 10.1 APP CST3
21 stroke, ischemic 10.1
22 leukoencephalopathy, hereditary diffuse, with spheroids 10.1 APP GFAP
23 prion disease 10.1 APP IL1B
24 aortic aneurysm, familial abdominal, 1 10.0 CST3 IL1B
25 infective endocarditis 10.0
26 ischemia 10.0
27 peripheral artery disease 10.0 APOB CST3
28 brain injury 9.9
29 leukemia 9.9
30 thrombocytopenia 9.9
31 dementia 9.9
32 amyotrophic lateral sclerosis 1 9.9 APP CST3 GFAP
33 end stage renal failure 9.9 APOB CST3
34 toxic encephalopathy 9.9 APP GFAP IL1B
35 nervous system disease 9.9 APP GFAP IL1B
36 central nervous system disease 9.9 APP GFAP IL1B
37 choriocarcinoma 9.9
38 cerebrovascular disease 9.9
39 encephalopathy 9.9
40 glucose metabolism disease 9.8 APOB IL1B
41 pheochromocytoma 9.8
42 moyamoya disease 1 9.8
43 acute promyelocytic leukemia 9.8
44 traumatic brain injury 9.8
45 angiosarcoma 9.8
46 cerebral artery occlusion 9.8
47 sarcoma 9.8
48 arteriovenous malformation 9.8
49 purpura 9.8
50 meningitis 9.8

Graphical network of the top 20 diseases related to Cerebral Hemorrhage:



Diseases related to Cerebral Hemorrhage

Symptoms & Phenotypes for Cerebral Hemorrhage

UMLS symptoms related to Cerebral Hemorrhage:


seizures, tremor, angina pectoris, edema, back pain, pain, chest pain, headache, syncope, chronic pain, sciatica, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Cerebral Hemorrhage:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 APOB APP CST3 GFAP IL1B
2 muscle MP:0005369 8.92 APOB APP CST3 GFAP

Drugs & Therapeutics for Cerebral Hemorrhage

Drugs for Cerebral Hemorrhage (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 370)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cilostazol Approved, Investigational Phase 4,Phase 3,Not Applicable 73963-72-1 2754
2
Probucol Approved, Investigational Phase 4 23288-49-5 4912
3
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
4
Enoxaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6 772
5
Nicardipine Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 55985-32-5 4474
6
Nadroparin Approved, Investigational Phase 4
7
Heparin Approved, Investigational Phase 4,Phase 3,Not Applicable 9005-49-6 772 46507594
8
Dalteparin Approved Phase 4,Phase 2 9005-49-6
9
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
10
Cisatracurium Approved Phase 4,Not Applicable 96946-41-7
11
Warfarin Approved Phase 4,Phase 3,Not Applicable 81-81-2 6691 54678486
12
Phytonadione Approved, Investigational Phase 4,Phase 3,Not Applicable,Early Phase 1 84-80-0 4812 5284607
13 tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
15
Simvastatin Approved Phase 4,Phase 2,Not Applicable 79902-63-9 54454
16
Clevidipine Approved, Investigational Phase 4,Phase 3,Phase 2 167221-71-8
17
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
18
Mannitol Approved, Investigational Phase 4,Not Applicable 69-65-8 453 6251
19
Thrombin Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
20
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 113665-84-2, 120202-66-6 60606
21
Ticlopidine Approved Phase 4,Phase 3,Early Phase 1 55142-85-3 5472
22
Caffeine Approved Phase 4,Phase 1,Phase 2 58-08-2 2519
23
Ticagrelor Approved Phase 4 274693-27-5 9871419
24
Olmesartan Approved, Investigational Phase 4 144689-63-4, 144689-24-7 158781 130881
25
Angiotensin II Approved, Investigational Phase 4,Phase 3 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
26
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
27
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
28
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 5282452 6366718
29
Ezetimibe Approved Phase 4 163222-33-1 150311
30
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
31
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Not Applicable 437-38-7 3345
32
Succinylcholine Approved Phase 4,Not Applicable 306-40-1 5314
33
Betamethasone Approved, Vet_approved Phase 4,Not Applicable 378-44-9 9782
34
Midazolam Approved, Illicit Phase 4,Not Applicable 59467-70-8 4192
35
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
36
Desflurane Approved Phase 4 57041-67-5 42113
37
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
38
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
39
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
40
Etomidate Approved Phase 4,Not Applicable 33125-97-2 667484 36339
41
Losartan Approved Phase 4 114798-26-4 3961
42
Lisinopril Approved, Investigational Phase 4 83915-83-7, 76547-98-3 5362119
43
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
44
Furosemide Approved, Vet_approved Phase 4 54-31-9 3440
45
Menadione Approved, Nutraceutical Phase 4,Phase 3,Not Applicable,Early Phase 1 58-27-5 4055
46
Ginseng Approved, Investigational, Nutraceutical Phase 4 50647-08-0
47
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
48 Urapidil Investigational Phase 4,Phase 3,Not Applicable 34661-75-1
49 Phosphodiesterase Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
50 Vasodilator Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 518)
# Name Status NCT ID Phase Drugs
1 Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Unknown status NCT01918722 Phase 4 ICH-1(herbal medicine with Hirudo, Tabanus);placebo;ICH-2(herbal medicine without Hirudo, Tabanus)
2 PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage Unknown status NCT01013532 Phase 4 Cilostazol;Probucol;Aspirin;placebo of cilostazol;placebo of aspirin
3 PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study Unknown status NCT02483169 Phase 4 cilostazol;Probucol;Aspirin;placebo of cilostazol;Placebo of aspirin
4 Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage Unknown status NCT00699465 Phase 4 enoxaparin;enoxaparin placebo
5 IV Double and Triple Concentrated Nicardipine for Stroke and ICH Unknown status NCT00325793 Phase 4 Nicardipine
6 Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Unknown status NCT02224209 Phase 4
7 Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD Unknown status NCT01531829 Phase 4 Recombinant tissue plasminogen activator (rt-PA);Low Molecular Weight Heparin
8 The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Unknown status NCT00724724 Phase 4 Butylphthalide Soft Capsules;Aspirin
9 The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris Unknown status NCT02870764 Phase 4 Dan-shen extract;Placebo
10 Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents Unknown status NCT02404779 Phase 4 cisatracurium besilate
11 Seizures Post Intracerebral Hemorrhage Completed NCT01115959 Phase 4 valproic acid;placebo bid
12 Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin Completed NCT02999048 Phase 4 Panax Notoginseng Saponins
13 International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage Completed NCT00928915 Phase 4 Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
14 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed NCT00234065 Phase 4 Cilostazol;Aspirin
15 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Completed NCT00814268 Phase 4 Clopidogrel;Clopidogrel placebo;Aspirin
16 Temperature Control in Central Fever in the Neuro-ICU Completed NCT00751634 Phase 4
17 MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Completed NCT00809055 Phase 4 Caffeine citrate
18 Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System Completed NCT00197392 Phase 4
19 A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting Completed NCT02330640 Phase 4 ticagrelor;clopidogrel;asprin
20 OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Completed NCT00134160 Phase 4 Olmesartan medoxomil;Calcium channel blockers (amlodipine, azelnidipine)
21 Imaging Guided Patient Selection for Interventional Revascularization Therapy Completed NCT00963989 Phase 4
22 Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT) Completed NCT00301392 Phase 4 Life style interventions plus concomitant use of pitavastatin.
23 Continuous Glucose Monitoring and Preterm Infants Completed NCT02583776 Phase 4
24 Study of Heart and Renal Protection Completed NCT00125593 Phase 4 Simvastatin 20 mg;Ezetimibe 10mg;Placebo
25 Danhong Injection in the Treatment of Chronic Stable Angina Completed NCT01681316 Phase 4 Danhong injection;Placebo
26 Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Recruiting NCT03300479 Phase 4 Clevidipine;Urapidil
27 Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial Recruiting NCT03772847 Phase 4 ginkgolide
28 Clopidogrel for Acute Ischaemia of Recent Onset Recruiting NCT02776540 Phase 4 Clopidogrel;Aspirin
29 Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke Recruiting NCT03661411 Phase 4 Aspirin;Clopidogrel 75mg;Alteplase
30 SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Recruiting NCT03263117 Phase 4 Sedation;General Anesthesia (GA)
31 Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism Recruiting NCT03090113 Phase 4 Shuxuetong Injection;Placebo Injection
32 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD Recruiting NCT03417388 Phase 4 High dose potent statin;ACE-I (lisinopril) or ARB (losartan);Aspirin
33 Danhong Injection in the Treatment of Acute Ischemic Stroke Recruiting NCT01677208 Phase 4 Danhong injection;placebo
34 ASCEND: A Study of Cardiovascular Events iN Diabetes Active, not recruiting NCT00135226 Phase 4 aspirin;Omega-3-acid Ethyl Esters;Placebo Aspirin;Placebo omega-3-Ethyl Esters
35 Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Not yet recruiting NCT03354026 Phase 4 AICH-PXZY;AICH-without PXZY;AICH-placebo
36 Study of Antithrombotic Treatment After Intracerebral Haemorrhage Not yet recruiting NCT03186729 Phase 4 Antithrombotic Agent
37 Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS) Not yet recruiting NCT03743103 Phase 4 Brevibloc, 10 Mg/mL Intravenous Solution;Nitroprusside, Sodium
38 Intervention for High-normal or Borderline-elevated Blood Pressure in Adults With Type 2 Diabetes Not yet recruiting NCT03264352 Phase 4 Allisartan Isoproxil;Amlodipine 5mg;Hydrochlorothiazide 25 mg;Allisartan Isoproxil placebo;Amlodipine placebo;Hydrochlorothiazide placebo
39 OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial Not yet recruiting NCT03759938 Phase 4 Direct oral anticoagulant (DOAC)
40 Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction Not yet recruiting NCT03797729 Phase 4 Tirofiban;Normal saline
41 Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth Terminated NCT00295464 Phase 4 Betamethasone sodium phos (drug)
42 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
43 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Withdrawn NCT01042574 Phase 4 Clevidipine butyrate
44 Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage Unknown status NCT00815737 Phase 2, Phase 3 rhubarb;Placebo
45 Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia Unknown status NCT01221142 Phase 3
46 Edoxaban for TIA and Acute Minor Stroke Unknown status NCT02221102 Phase 2, Phase 3 Aspirin;edoxaban;placebo
47 Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Unknown status NCT01923818 Phase 2, Phase 3 rivaroxaban;Aspirin;placebo
48 Clinical Value of Noninvasive Intracranial Pressure Measurement Unknown status NCT02130219 Phase 2, Phase 3
49 Management of Hypotension In the Preterm Infant Unknown status NCT01482559 Phase 3 Dopamine hydrochloride;Dextrose 5%
50 Prophylactic Acetaminophen for Prevention Intraventricular Hemorrhage in Premature Infants Unknown status NCT03024814 Phase 3 Acetaminophen;Dextrose 5

Search NIH Clinical Center for Cerebral Hemorrhage

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Cerebral Hemorrhage cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Cerebral Hemorrhage:
GLP-1 CellBeads�, encapsulated mesenchymal stem cells for intracerebral hemorrhage
Embryonic/Adult Cultured Cells Related to Cerebral Hemorrhage:
GLP-transfected mesenchymal stem cells PMIDs: 22985173 22034462

Genetic Tests for Cerebral Hemorrhage

Genetic tests related to Cerebral Hemorrhage:

# Genetic test Affiliating Genes
1 Cerebral Hemorrhage 29

Anatomical Context for Cerebral Hemorrhage

MalaCards organs/tissues related to Cerebral Hemorrhage:

41
Brain, Heart, Bone, Neutrophil, Liver, Spinal Cord, T Cells

Publications for Cerebral Hemorrhage

Articles related to Cerebral Hemorrhage:

(show top 50) (show all 671)
# Title Authors Year
1
Time-effect relationship of acupuncture on histopathology, ultrastructure, and neuroethology in the acute phase of cerebral hemorrhage. ( 30531084 )
2019
2
Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. ( 29844891 )
2018
3
Related Factors of Early Mortality in Young Adults with Cerebral Hemorrhage. ( 29915811 )
2018
4
Response by Fouda and Switzer to Letter Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183950 )
2018
5
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility. ( 29017932 )
2018
6
Lethal cerebral hemorrhage after ticagrelor intoxication: a specific antidote is urgently needed. ( 29889575 )
2018
7
Theaflavin alleviates inflammatory response and brain injury induced by cerebral hemorrhage via inhibiting the nuclear transcription factor kappa I^-related pathway in rats. ( 29928110 )
2018
8
Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. ( 29643882 )
2018
9
Cerebral Venous Sinus Thrombosis with Cerebral Hemorrhage Presenting with Status Epilepticus in Early Pregnancy. ( 29739085 )
2018
10
Recurrent Cerebral Hemorrhage in Normal Pregnancy Secondary to Mycotic Pseudoaneurysms Related to Choriocarcinoma. ( 28987845 )
2018
11
Fetal Cerebral Hemorrhage due to X-linked GATA1 gene mutation. ( 29949202 )
2018
12
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy). ( 29433151 )
2018
13
Relationship Between Short Term Variability (STV) and Onset of Cerebral Hemorrhage at Ischemia-Reperfusion Load in Fetal Growth Restricted (FGR) Mice. ( 29867536 )
2018
14
Influence of tranexamic acid on cerebral hemorrhage: A meta-analysis of randomized controlled trials. ( 29929173 )
2018
15
Fatal cerebral hemorrhage in a tetraplegic patient due to autonomic dysreflexia triggered by delay in emptying urinary bladder after unsuccessful intermittent catheterization by carer: lessons learned. ( 29563843 )
2018
16
Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation. ( 29928111 )
2018
17
Letter by Chang et al Regarding Article, "Minocycline in Acute Cerebral Hemorrhage: An Early Phase Randomized Trial". ( 29183951 )
2018
18
Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets. ( 29737222 )
2018
19
A case of Cardiobacterium valvarum endocarditis with cerebral hemorrhage after MVR, TVP and vegetation removal operation. ( 29566704 )
2018
20
Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. ( 29247070 )
2018
21
Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type. ( 29706885 )
2018
22
Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage. ( 30027390 )
2018
23
Impact of Supratentorial Cerebral Hemorrhage on the Complexity of Heart Rate Variability in Acute Stroke. ( 30065287 )
2018
24
SP100B Expression Indexed Hemorrhage in Mouse Models of Cerebral Hemorrhage. ( 30072838 )
2018
25
Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review. ( 30090954 )
2018
26
Acute Blood Pressure Management in Acute Ischemic Stroke and Spontaneous Cerebral Hemorrhage. ( 30121736 )
2018
27
A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn. ( 30151288 )
2018
28
Catastrophic cerebral hemorrhage and edema in a patient with pneumococcal meningitis. ( 30216857 )
2018
29
Comparison of Thrombelastography (TEG) in Patients with Acute Cerebral Hemorrhage and Cerebral Infarction. ( 30217969 )
2018
30
MiR-7 alleviates secondary inflammatory response of microglia caused by cerebral hemorrhage through inhibiting TLR4 expression. ( 30229834 )
2018
31
Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside. ( 30254628 )
2018
32
Clinical outcomes depending on acute blood pressure after cerebral hemorrhage. ( 30421455 )
2018
33
Previous chronic symptomatic and asymptomatic cerebral hemorrhage in patients with acute ischemic stroke. ( 30488255 )
2018
34
Large B-cell lymphoma concommittant to intra-cerebral hemorrhage. ( 30500092 )
2018
35
Correlations of Acute Cerebral Hemorrhage Complicated with Stress Ulcer Bleeding with Acute Physiology and Chronic Health Evaluation (APACHE) II Score, Endothelin (ET), Tumor Necrosis Factor-alpha (TNF-α), and Blood Lipids. ( 30554231 )
2018
36
Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy. ( 28090058 )
2017
37
Cerebral hemorrhage in monozygotic twins with hereditary hemorrhagic telangiectasia: case report and hemorrhagic risk evaluation. ( 28524787 )
2017
38
Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. ( 28342065 )
2017
39
Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: AA Prospective Cohort Study. ( 28969928 )
2017
40
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. ( 28595677 )
2017
41
Response by Werring and Charidimou to Letter Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030477 )
2017
42
Design and Rationale of the Intima-Medial Thickness Sub-Study of the PreventIon of CArdiovascular Events in iSchemic Stroke Patients with High Risk of Cerebral hemOrrhage (PICASSO-IMT) Study. ( 28739344 )
2017
43
Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. ( 28720659 )
2017
44
Cerebral Hemorrhage following Chiropractic Activator Treatment: Case Report and Review of Literature. ( 28884069 )
2017
45
Cerebral hemorrhage as the initial manifestation in patients with systemic cancer. ( 28724319 )
2017
46
Author's Response to Letter to the Editor: Cerebral Hemorrhage Following Chiropractic Activator Treatment-Case Report and Review of the Literature. ( 29034908 )
2017
47
Letter by Tsivgoulis et al Regarding Article, "Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis". ( 29030473 )
2017
48
Cerebral hemorrhage therapy by targeting VEGF and HGF in a preclinical trial in rats. ( 28339025 )
2017
49
A Systematic Review and Meta-Analysis on the Treatment of Cerebral Hemorrhage with NaoXueShu Oral Liquid. ( 28630871 )
2017
50
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. ( 28356458 )
2017

Variations for Cerebral Hemorrhage

Expression for Cerebral Hemorrhage

Search GEO for disease gene expression data for Cerebral Hemorrhage.

Pathways for Cerebral Hemorrhage

Pathways related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.87 APP CST3 GFAP
2 10.64 IL1B KLK1
3 9.98 APP CST3

GO Terms for Cerebral Hemorrhage

Cellular components related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.72 APOB APP CST3 IL1B KLK1
2 endoplasmic reticulum lumen GO:0005788 9.43 APOB APP CST3
3 secretory granule GO:0030141 9.37 IL1B KLK1
4 smooth endoplasmic reticulum GO:0005790 9.16 APOB APP
5 endosome lumen GO:0031904 8.96 APOB APP
6 astrocyte projection GO:0097449 8.62 APP GFAP

Biological processes related to Cerebral Hemorrhage according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.58 APOB APP IL1B
2 positive regulation of DNA-binding transcription factor activity GO:0051091 9.49 APP IL1B
3 response to estradiol GO:0032355 9.48 APOB IL1B
4 cholesterol metabolic process GO:0008203 9.46 APOB APP
5 positive regulation of JNK cascade GO:0046330 9.43 APP IL1B
6 post-translational protein modification GO:0043687 9.43 APOB APP CST3
7 negative regulation of neuron differentiation GO:0045665 9.37 APP IL1B
8 cellular protein metabolic process GO:0044267 9.33 APOB APP CST3
9 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.32 APP IL1B
10 positive regulation of glial cell proliferation GO:0060252 8.96 GFAP IL1B
11 response to carbohydrate GO:0009743 8.62 APOB IL1B

Sources for Cerebral Hemorrhage

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....